MiniMed Group (MMED)
Builds integrated insulin-delivery and glucose-monitoring systems for diabetes care.
$20.77
vs last close−0.43 (−2.05%)
Something off on this page? Send us feedback.
EPSReportedEstimate
—————Apr '26Jun '26Sep '26
Reported—————−$0.16−$0.68$0.12
Estimate—————$0.17−$0.15$0.12
Surprise—————−194.0%−356.2%−3.3%
RevenueReportedEstimate
—————Apr '26Jun '26Sep '26
Reported—————$790.0M$837.0M$843.0M
Estimate—————$789.5M$828.6M$826.8M
Surprise—————+0.1%+1.0%+2.0%
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Apr 2029 | $0.52 | — | — |
| Jan 2029 | $0.46 | — | — |
| Oct 2028 | $0.43 | — | — |
| Jul 2028 | $0.40 | — | — |
| Apr 2028 | $0.39 | — | — |
| Jan 2028 | $0.29 | — | — |
| Oct 2027 | $0.04 | — | — |
| Jul 2027 | −$0.01 | — | — |
| Apr 2027 | $0.28 | — | — |
| Jan 2027 | $0.21 | — | — |
| Oct 2026 | $0.14 | — | — |
| Sep 2026 | $0.12 | $0.12 | −3.3% |
| Jun 2026 | −$0.15 | −$0.68 | −356.2% |
| Apr 2026 | $0.17 | −$0.16 | −194.0% |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Apr 2029 | $0.52 | — | — | $1.10B | — | — | — |
| Jan 2029 | $0.46 | — | — | $1.00B | — | — | — |
| Oct 2028 | $0.43 | — | — | $971.4M | — | — | — |
| Jul 2028 | $0.40 | — | — | $951.4M | — | — | — |
| Apr 2028 | $0.39 | — | — | $997.8M | — | — | — |
| Jan 2028 | $0.29 | — | — | $938.8M | — | — | — |
| Oct 2027 | $0.04 | — | — | $911.1M | — | — | — |
| Jul 2027 | −$0.01 | — | — | $880.5M | — | — | — |
| Apr 2027 | $0.28 | — | — | $905.6M | — | — | — |
| Jan 2027 | $0.21 | — | — | $860.9M | — | — | — |
| Oct 2026 | $0.14 | — | — | $829.3M | — | — | — |
| Sep 1, 2026 | $0.12 | $0.12 | −3.3% | $826.8M | $843.0M | +2.0% | +10.7% |
| Jun 3, 2026 | −$0.15 | −$0.68 | −356.2% | $828.6M | $837.0M | +1.0% | +15.9% |
| Apr 17, 2026 | $0.17 | −$0.16 | −194.0% | $789.5M | $790.0M | +0.1% | −4.4% |
